Search Results - Bapsi Chakravarthy
- Showing 1 - 15 results of 15
-
1
-
2
Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy by Nkiruka C. Atuegwu, Lori R. Arlinghaus, Xia Li, A. Bapsi Chakravarthy, Vandana G. Abramson, Melinda E. Sanders, Thomas E. Yankeelov
Published 2013Artigo -
3
-
4
-
5
Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: Preliminary results by Richard G. Abramson, Xia Li, Tamarya L. Hoyt, Pei‐Fang Su, Lori R. Arlinghaus, Kevin J. Wilson, Vandana G. Abramson, A. Bapsi Chakravarthy, Thomas E. Yankeelov
Published 2013Artigo -
6
p53-Dependent BRCA1 Nuclear Export Controls Cellular Susceptibility to DNA Damage by Juhong Jiang, Eddy S. Yang, Guochun Jiang, Somaira Nowsheen, Hong Wang, Tong Wang, Yihan Wang, Dean Billheimer, A. Bapsi Chakravarthy, Melissa A. Brown, Bruce G. Haffty, Fen Xia
Published 2011Artigo -
7
A nonrigid registration algorithm for longitudinal breast MR images and the analysis of breast tumor response by Xia Li, Benoît M. Dawant, E. Brian Welch, A. Bapsi Chakravarthy, Darla Freehardt, Ingrid A. Mayer, Mark C. Kelley, Ingrid M. Meszoely, John C. Gore, Thomas E. Yankeelov
Published 2009Artigo -
8
-
9
Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival by Sylvia Adams, A. Bapsi Chakravarthy, Martin Donach, Darcy Spicer, S. Lymberis, Baljit Singh, Joshua A. Bauer, Tsivia Hochman, Judith D. Goldberg, Franco M. Muggia, Robert J. Schneider, Jennifer A. Pietenpol, Silvia C. Formenti
Published 2010Artigo -
10
A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer by Xia Li, E. Brian Welch, Lori R. Arlinghaus, A. Bapsi Chakravarthy, Lei Xu, Jaime Farley, Mary E. Loveless, Ingrid A. Mayer, Mark C. Kelley, Ingrid M. Meszoely, Julie A. Means‐Powell, Vandana G. Abramson, Ana M. Grau, John C. Gore, Thomas E. Yankeelov
Published 2011Artigo -
11
DCE‐MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findings by Xia Li, Lori R. Arlinghaus, Gregory D. Ayers, A. Bapsi Chakravarthy, Richard G. Abramson, Vandana G. Abramson, Nkiruka C. Atuegwu, Jaime Farley, Ingrid A. Mayer, Mark C. Kelley, Ingrid M. Meszoely, Julie Means‐Powell, Ana M. Grau, Melinda E. Sanders, Sandeep R. Bhave, Thomas E. Yankeelov
Published 2013Artigo -
12
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer by Mohan Suntharalingam, Kathryn Winter, David H. Ilson, Adam P. Dicker, Lisa A. Kachnic, André Konski, A. Bapsi Chakravarthy, Christopher J. Anker, H. Thakrar, Naomi Horiba, Ajay Kumar Dubey, Joel S. Greenberger, Adam Raben, Jeffrey K. Giguere, Kevin S. Roof, Gregory M.M. Videtic, Jondavid Pollock, Howard Safran, Christopher H. Crane
Published 2017Artigo -
13
Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial by William Small, Jordan Berlin, Gary M. Freedman, Theodore S. Lawrence, Mark S. Talamonti, Mary F. Mulcahy, A. Bapsi Chakravarthy, André Konski, Mark M. Zalupski, Philip A. Philip, Timothy J. Kinsella, Nipun B. Merchant, John P. Hoffman, Al B. Benson, Steven J. Nicol, Rong M. Xu, John F. Gill, Cornelius J. McGinn
Published 2008Artigo -
14
Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation by Joshua A. Bauer, A. Bapsi Chakravarthy, Jennifer M. Rosenbluth, Deming Mi, Erin H. Seeley, Nara De Matos Granja-Ingram, Maria G. Olivares, Mark C. Kelley, Ingrid A. Mayer, Ingrid M. Meszoely, Julie A. Means‐Powell, Kimberly N. Johnson, C. Jillian Tsai, Gregory D. Ayers, Melinda E. Sanders, Robert J. Schneider, Silvia C. Formenti, Richard M. Caprioli, Jennifer A. Pietenpol
Published 2010Artigo -
15
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors by Johanna M. Schafer, Brian D. Lehmann, Paula I. González-Ericsson, Clayton B. Marshall, J. Scott Beeler, Lindsay N. Redman, Hailing Jin, Violeta Sánchez, Matthew C. Stubbs, Peggy Scherle, Kimberly N. Johnson, Quanhu Sheng, Joseph T. Roland, Joshua A. Bauer, Yu Shyr, Bapsi Chakravarthy, Bret C. Mobley, Scott W. Hiebert, Justin M. Balko, Melinda E. Sanders, Phillip C.C. Liu, Jennifer A. Pietenpol
Published 2020Artigo
Search Tools:
Related Subjects
Cancer
Internal medicine
Medicine
Breast cancer
Biology
Magnetic resonance imaging
Radiology
Chemotherapy
Oncology
Radiation therapy
Cancer research
Neoadjuvant therapy
Nuclear medicine
Pathology
Artificial intelligence
Breast MRI
Computer science
Diffusion MRI
Mammography
Surgery
Voxel
Cell biology
Environmental health
Gene
Genetics
Paclitaxel
Paleontology
Pancreatic cancer
Pathological
Physics